Reuters logo
UPDATE 1-AstraZeneca wins temporary block on Actavis asthma drug
April 3, 2013 / 11:06 AM / in 5 years

UPDATE 1-AstraZeneca wins temporary block on Actavis asthma drug

LONDON, April 3 (Reuters) - AstraZeneca has secured a temporary block on U.S. sales of generic copies of its Pulmicort Repsules asthma drug by Actavis.

Actavis said on Wednesday a New Jersey district court granted the temporary restraining order preventing further distribution of its generic version of the medicine until April 12.

The decision gives AstraZeneca time to appeal against a ruling two days ago that declared a patent on Pulmicort Repsules to be invalid.

Teva already has a generic form the drug on the market following an earlier deal with AstraZeneca.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below